Antibodies have established themselves as one of the most important classes within the biologics space, and developing these therapeutics requires a series of successful decisions throughout the early-discovery process.
Watch Now
esc365
After watching this webinar, participants will understand: current clinical evidence for the percutaneous treatment of structural heart disease; indications for the transcatheter treatment of symptomatic, significant aortic valve stenosis or mitral regurgitation; optimal patient selection for left atrial appendage occlusion; and the recommended training pathways for structural heart disease.
Watch Now
How is the growing synthetic biology sector evolving, why is it growing exponentially, and what are key players doing to stake their claim in an already crowded field that’s spurring an industry transition toward greater sustainability?
Watch Now
Current protein biomarkers are only moderately predictive in identifying individuals with mild traumatic brain injury or concussion. Therefore, more accurate diagnostic markers are needed for sport-related concussion.
Watch Now